It is possible that growth hormone can offer therapeutic benefits for treating some forms of heart failure.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia
Journal of Cachexia, Sarcopenia and Muscle Open Access 17 December 2010
-
Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-κB activity
British Journal of Cancer Open Access 09 September 2003
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Saccà, L., Cittadini, A. & Fazio, S. Growth hormone and the heart. Endocr. Rev. 15, 555–573 (1994).
Duerr, R.L. et al. Insulin-like growth factor-I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J. Clin. Invest. 95, 619–627 (1995).
Yang, R., Bunting, S., Gillett, N., Clark, R. & Jin, H. Growth hormone improves cardiac performance in experimental heart failure. Circulation 92, 262–267 (1995).
Flyvbjerg, A., Jørgensen, K.D., Marshall, S.M. & ørskov, H. Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats. Am. J. Physiol. 260, E568–E574 (1991).
Timsit, J. et al. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energet ics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. J. Clin. Invest. 86, 507–515 (1990).
Jørgensen, J.O.L. et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1, 1221–1225 (1989).
Ito, H. et al. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulations 87, 1715–1721 (1993).
Wåhlander, H., Isgaard, J., Jennische, E. & Friberg, P. Left ventricular insulin-like growth factor I increases in early renal hypertension. Hypertension 19, 25–32 (1992).
Donohue, T.J. et al. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation 89, 799–809 (1994).
Baker, J., Liu, J.-P., Robertson, E.J. & Efstratiadis, A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75, 73–82 (1993).
Rosén, T. & Bengtsson, B.-Å. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336, 285–288 (1990).
Cuneo, R.C., Wilmshurst, P., Lowy, C., McGauley, G. & Sønksen, P.H. Cardiac failure responding to growth hormone. Lancet 1, 838–839 (1989)
Frustaci, A., Perrone, G.A., Gentiloni, N. & Russo, M.A. Reversible dilated cardiomyopathy due to growth hormone deficiency. Am. J. Clin. Pathol. 97, 503–511 (1992).
Pfeffer, M.A. et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N. Engl. J. Med. 327, 669–677 (1992).
Lompre, A.M. et al. Myosin isoenzyme redistribution in chronic heart overload. Nature 282, 105–107 (1979).
Izumo, S., Nadal-Ginard, B. & Mahdavi, V. All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. Science 231, 597–600 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saccà, L., Fazio, S. Cardiac performance: Growth hormone enters the race. Nat Med 2, 29–31 (1996). https://doi.org/10.1038/nm0196-29
Issue Date:
DOI: https://doi.org/10.1038/nm0196-29
This article is cited by
-
Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia
Journal of Cachexia, Sarcopenia and Muscle (2010)
-
Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-κB activity
British Journal of Cancer (2003)
-
Lack of effects of recombinant human growth hormone in a child with a complex cardiovascular malformation and dilated cardiomyopathy
Journal of Endocrinological Investigation (2000)